A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People
Purpose
The purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together. This study is seeking healthy participants aged 18 or older. All participants in this study will receive only 1 shot to their arm, either a flu or COVID vaccine, alone or mixed. Participants will take part in this study for about 6 months, and participants will need to visit the clinical study site at least 4 times.
Conditions
- Influenza
- COVID-19 (Coronavirus Disease 2019)
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Participants 18 years of age or older - Healthy participants who are determined by medical history, physical examination (if clinically required), and clinical judgement of the investigator to be eligible for inclusion in the study
Exclusion Criteria
- Vaccination with any investigational or licensed influenza vaccine within 150 days of enrollment - Vaccination with any investigational or licensed COVID 19 vaccine within 150 days of enrollment. - Receipt of antiviral therapies for influenza (eg, Tamiflu) within 180 days prior to Day 1. Refer to the study contact for further eligibility details
Study Design
- Phase
- Phase 1/Phase 2
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Prevention
- Masking
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
Experimental Arm A |
Low Dose COVID-19 Vaccine (1a) |
|
Experimental Arm B |
Low Dose COVID-19 Vaccine ( 1b) |
|
Experimental Arm C |
Low Dose COVID-19 Vaccine ( 1c) |
|
Experimental Arm D |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 1) |
|
Experimental Arm E |
Investigational Influenza and COVID-19 Combination Vaccine (Medium Dose Combination 2) |
|
Experimental Arm F |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 3) |
|
Experimental Arm G |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 4) |
|
Active Comparator Arm H |
Licensed COVID-19 Vaccine |
|
Active Comparator Arm I |
Licensed Influenza Vaccine (1) |
|
Experimental Arm J |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 5) |
|
Experimental Arm K |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 6) |
|
Experimental Arm L |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 7) |
|
Active Comparator Arm M |
Licensed COVID-19 Vaccine |
|
Active Comparator Arm N |
Licensed Influenza Vaccine (2) |
|
Experimental Arm AA |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 6) |
|
Experimental Arm BB |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 4) |
|
Experimental Arm CC |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 7) |
|
Experimental Arm DD |
Investigational Influenza and COVID-19 Combination Vaccine (Medium Dose Combination 2) |
|
Experimental Arm EE |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 3) |
|
Active Comparator Arm FF |
Licensed COVID-19 Vaccine |
|
Active Comparator Arm GG |
Licensed Influenza Vaccine (3) |
|
Active Comparator Arm HH |
Licensed Influenza Vaccine (2) |
|
Experimental Arm II |
Low Dose COVID-19 Vaccine ( 1b) |
|
Experimental Arm JJ |
Low Dose COVID-19 Vaccine ( 1c) |
|
Experimental Arm KK |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 4) |
|
Experimental Arm LL |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 7) |
|
Experimental Arm MM |
Investigational Influenza and COVID-19 Combination Vaccine (Medium Dose Combination 2) |
|
Experimental Arm NN |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 3) |
|
Experimental Arm OO |
Investigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 5) |
|
Experimental Arm PP |
Medium Dose Investigational Influenza Vaccine (1) |
|
Experimental Arm QQ |
High Dose Investigational Influenza Vaccine (2) |
|
Active Comparator Arm RR |
Licensed COVID-19 Vaccine |
|
Active Comparator Arm SS |
Licensed Influenza Vaccine (3) |
|
Recruiting Locations
Anaheim Clinical Trials, LLC
Anaheim, California 92801
Anaheim, California 92801
Orange County Research Center
Lake Forest, California 92630
Lake Forest, California 92630
Artemis Institute for Clinical Research
Riverside, California 92503
Riverside, California 92503
Artemis Institute for Clinical Research
San Diego, California 92103
San Diego, California 92103
Diablo Clinical Research, Inc.
Walnut Creek, California 94598
Walnut Creek, California 94598
Clinical Research Consulting
Milford, Connecticut 06460
Milford, Connecticut 06460
Alliance for Multispecialty Research, LLC
Coral Gables, Florida 33134
Coral Gables, Florida 33134
Indago Research & Health Center, Inc
Hialeah, Florida 33012
Hialeah, Florida 33012
Palm Springs Community Health Center
Miami Lakes, Florida 33014
Miami Lakes, Florida 33014
Miami Dade Medical Research Institute, LLC
Miami, Florida 33176
Miami, Florida 33176
Clinical Research Atlanta
Stockbridge, Georgia 30281
Stockbridge, Georgia 30281
East-West Medical Research Institute
Honolulu, Hawaii 96814
Honolulu, Hawaii 96814
Clinical Research Professionals
Chesterfield, Missouri 63005
Chesterfield, Missouri 63005
Las Vegas Clinical Trials
North Las Vegas, Nevada 89030
North Las Vegas, Nevada 89030
Upstate Global Health Institute
East Syracuse, New York 13057
East Syracuse, New York 13057
University of Rochester Medical Center
Rochester, New York 14642
Rochester, New York 14642
Trial Management Associates - Wilmington - Floral Parkway
Wilmington, North Carolina 28403
Wilmington, North Carolina 28403
Centricity Research Columbus Ohio Multispecialty
Columbus, Ohio 43213
Columbus, Ohio 43213
DM Clinical Research - Philadelphia
Philadelphia, Pennsylvania 19107
Philadelphia, Pennsylvania 19107
Coastal Carolina Research Center
North Charleston, South Carolina 29405
North Charleston, South Carolina 29405
AMR Clinical
Knoxville, Tennessee 37909
Knoxville, Tennessee 37909
AMR Clinical
Knoxville, Tennessee 37920
Knoxville, Tennessee 37920
Clinical Research Associates Inc
Nashville, Tennessee 37203
Nashville, Tennessee 37203
Headlands Horizons, LLC dba Headlands Research-Brownsville
Brownsville, Texas 78526
Brownsville, Texas 78526
DM Clinical Research- Cyfair
Houston, Texas 77065
Houston, Texas 77065
SMS Clinical Research
Mesquite, Texas 75149
Mesquite, Texas 75149
Dynamed Clinical Research, LP d/b/a DM Clinical Research
Tomball, Texas 77375
Tomball, Texas 77375
J. Lewis Research, Inc. / Foothill Family Clinic
Salt Lake City, Utah 84109
Salt Lake City, Utah 84109
J. Lewis Research, Inc. / Foothill Family Clinic South
Salt Lake City, Utah 84121
Salt Lake City, Utah 84121
Charlottesville Medical Research
Charlottesville, Virginia 22911
Charlottesville, Virginia 22911
Kaiser Permanente Washington Health Research Institute (KPWHRI)
Seattle, Washington 98101
Seattle, Washington 98101
More Details
- NCT ID
- NCT06821061
- Status
- Recruiting
- Sponsor
- BioNTech SE